Related Experiment Videos
Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2
Abstract:
Many human tumours show perturbations of a pathway that includes the D-cyclins, their associated cyclin-dependent kinases, and specific kinase inhibitors. The focal point of this pathway is the product of the retinoblastoma tumour suppressor gene, pRb, which imposes a block on G1 phase progression. Thus, the major role of the cyclin D-dependent kinases is to overcome this block by initiating the phosphorylation of pRb. Excessive activity of this pathway is likely to lead to excessive cell proliferation. Conversely, accumulation of the inhibitors is associated with the cessation of cell division.
Insights
Dysregulated cell cycle pathways, involving D-cyclins and retinoblastoma protein (pRb), are common in human tumors. Overactive cyclin D-dependent kinases drive excessive cell proliferation, while inhibitors halt cell division.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Human tumors frequently exhibit alterations in cell cycle regulation.
- The D-cyclin pathway, including cyclin-dependent kinases and inhibitors, plays a critical role in cell cycle control.
- The retinoblastoma protein (pRb) is a key regulator of the G1/S phase transition, acting as a tumor suppressor.
Purpose of the Study:
- To elucidate the role of the D-cyclin pathway in human tumorigenesis.
- To understand how perturbations in this pathway lead to uncontrolled cell proliferation.
- To investigate the function of cyclin-dependent kinases and their inhibitors in regulating pRb.
Main Methods:
- Analysis of D-cyclin pathway components in tumor samples.
- Investigation of cyclin-dependent kinase activity and pRb phosphorylation.
- Assessment of the impact of pathway inhibitors on cell cycle progression.
Main Results:
- Perturbations in the D-cyclin pathway are a hallmark of many human tumors.
- Overactive cyclin D-dependent kinases promote cell proliferation by phosphorylating pRb, overcoming the G1 block.
- Accumulation of specific kinase inhibitors leads to the cessation of cell division.
Conclusions:
- The D-cyclin pathway is a critical regulator of cell proliferation and a frequent target in cancer.
- Targeting cyclin-dependent kinases or enhancing inhibitor activity may offer therapeutic strategies for cancer treatment.